A phase II trial to assess the activity of TroVax alone vs TroVax plus interferon alfa (IFN-alpha) on patients with advanced or metastatic renal cell cancer
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2016
At a glance
- Drugs MVA 5T4 (Primary) ; Interferon alpha
- Indications Renal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2009 Updated results presented at ASCO 2009.
- 24 Aug 2008 Status changed from active, no longer recruiting to completed.